Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 191

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 191
---
 Bay Ltd. Each of Mr. Bistricer and Murchinson disclaims any beneficial ownership of these shares except of any pecuniary interests therein. The principal business address of Murchinson is 145 Adelaide Street West, Fourth Floor, Toronto ON M5H4E5. |

| (11) | Comprised of 176,000 shares of Common Stock being registered for resale under this Prospectus issuable upon the exercise of the September 2025 Warrants issued to the Selling Stockholder. |

117

| (12) | Consists of 12,209 shares of Common Stock underlying the November 2025 Placement Agent Warrants held by the Selling Stockholder exercisable within 60 days of December 5, 2025. The business address of Wilson Drive Holdings LLC is 600 Lexington Ave, 32nd Floor, New York, NY 10022. |

| (13) | Comprised of 12,209 shares of Common Stock being registered for resale under this Prospectus issuable upon the exercise of the November 2025 Placement Agent Warrants issued to the Selling Stockholder. |

118

PLAN OF DISTRIBUTION We are registering the issuance by us of up to 500,000 shares of our Common Stock that are issuable upon exercise of the Exchange Warrants. We will receive proceeds from the Exchange Warrants exercised in the event that such Exchange Warrants are exercised for cash. A holder of Exchange Warrants may exercise its Exchange Warrants in accordance with its terms on or before the expiration date set forth in the Exchange Warrant by surrendering the certificate evidencing such Exchange Warrant, with the form of election to purchase set forth thereon, properly completed and duly executed, accompanied by full payment of the exercise price and any and all applicable taxes due in connection with the exercise of the Exchange Warrant, subject to any applicable provisions relating to cashless exercises in accordance with the Warrant Exchange Agreement. This offering will terminate on the date that all shares of our Common Stock offered by this prospectus have been issued upon exercise of the Exchange Warrants or the Exchange Warrants are otherwise no longer outstanding. We are also registering the offer and sale from time to time by the Selling Stockholders of up to an aggregate of 1,703,946 Resale Shares. We will not receive any proceeds from the sale by the Selling Stockholders of the securities offered by them described in this prospectus, except with respect to amounts received by us upon the exercise of the September 2025